Amy Burroughs's most recent trade in Tenaya Therapeutics Inc was a trade of 120,000 Stock Option (Right to buy) done . Disclosure was reported to the exchange on May 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2026 | 120,000 | 120,000 | - | - | Stock Option (Right to buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2026 | 1,250,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2026 | 955,534 | 0 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2026 | 300,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 53.00 per share. | 05 May 2026 | 150,000 | 0 | - | 53 | 7,950,000 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | 05 May 2026 | 146,614 | 0 | - | 53 | 7,770,542 | Common Stock | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | 05 May 2026 | 8,319 | 0 | - | 53 | 440,907 | Common Stock | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 14,583 | 955,534 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share. | 16 Mar 2026 | 14,583 | 303,559 | - | 4.6 | 67,665 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.57 per share. | 16 Mar 2026 | 11,813 | 291,746 | - | 46.6 | 550,081 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.30 per share. | 16 Mar 2026 | 2,770 | 288,976 | - | 47.3 | 131,028 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share. | 17 Feb 2026 | 14,583 | 303,559 | - | 4.6 | 67,665 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2026 | 14,583 | 970,117 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 17 Feb 2026 | 8,159 | 293,059 | - | 39.2 | 319,963 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.80 per share. | 17 Feb 2026 | 4,083 | 288,976 | - | 39.8 | 162,501 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.07 per share. | 17 Feb 2026 | 2,341 | 301,218 | - | 38.1 | 89,114 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 150,000 | 288,976 | - | 0 | Common Stock | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.02 per share. | 14 Jan 2026 | 61,228 | 296,497 | - | 37.0 | 2,266,373 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2026 | 27,083 | 999,283 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2026 | 27,083 | 1,026,366 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share. | 14 Jan 2026 | 27,083 | 316,059 | - | 4.6 | 125,665 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share. | 14 Jan 2026 | 27,083 | 343,142 | - | 4.6 | 125,665 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share. | 14 Jan 2026 | 14,583 | 357,725 | - | 4.6 | 67,665 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2026 | 14,583 | 984,700 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.53 per share. | 14 Jan 2026 | 7,521 | 288,976 | - | 37.5 | 282,230 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 150,000 | 210,315 | - | - | Common Stock | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 150,000 | 0 | - | - | Restricted Stock Unit | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.10 per share. | 02 Jan 2026 | 71,339 | 138,976 | - | 38.1 | 2,718,230 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.64 per share. | 02 Jan 2026 | 21,551 | 60,315 | - | 4.6 | 99,997 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 21,551 | 1,053,449 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 25 Jun 2025 | 23,314 | 47,083 | - | 3.9 | 90,230 | Common Stock |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 107,400 | 107,400 | - | - | Stock Option (Right to buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 1,075,000 | 1,075,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 30 Jan 2025 | 510 | 19,609 | - | 5.1 | 2,606 | Common Stock |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.15 per share. | 05 Dec 2024 | 15,450 | 19,099 | - | 7.2 | 110,468 | Common Stock |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,250,000 | 1,250,000 | - | - | Stock Option (Right to buy) | |
| Terns Pharma Inc | Amy Burroughs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 150,000 | 150,000 | - | - | Restricted Stock Unit | |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 14,766 | 14,766 | - | - | Stock Option (Right to buy) | |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 1.53 per share. | 03 Jan 2023 | 17,156 | 73,288 (0%) | 0% | 1.5 | 26,249 | Voting Common Shares, no par value per share |
| Tenaya Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to buy) | |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 3.58 per share. | 03 Jan 2022 | 11,182 | 56,132 (0%) | 0% | 3.6 | 40,032 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Amy Burroughs | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 16 Aug 2021 | 44,950 | 44,950 (0%) | 0% | 3.2 | 141,593 | Voting Common Shares, no par value per share |